Compositions and methods for treating mucositis
US-2024415798-A1 · Dec 19, 2024 · US
US9504662B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9504662-B2 |
| Application number | US-39047610-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 20, 2010 |
| Priority date | Aug 20, 2009 |
| Publication date | Nov 29, 2016 |
| Grant date | Nov 29, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed is herein a composition comprising hexamidines, derivatives thereof, or pharmaceutically acceptable salts thereof; and retinoids, derivatives thereof, or pharmaceutically acceptable salts thereof, as an active ingredient. The composition of the present invention has effects for preventing, improving or treating acne; controlling sebum; pore-controlling; and preventing, improving or treating skin pigmentation. Also, the composition of the present invention could alleviate skin-irritations caused with retinoids by including ceramides.
Opening claim text (preview).
We claim: 1. A method for improving skin condition of a subject, comprising: administering to the subject a composition comprising an effective amount of hexamidine, retinol, and ceramide that improve skin condition in the subject; wherein the ceramide is in an amount of 0.2 wt % to 5.0 wt % based on a total weight of the composition; wherein the hexamidine is in an amount of 0.1 wt % based on the total weight of the composition, wherein the retinol is in an amount of 0.05 wt % to 0.3 wt % based on the total weight of the composition, wherein the improving skin condition of the subject is selected from the group consisting of improving or treating acne of the subject, controlling sebum of the subject, controlling pores of the subject, and improving or treating skin pigmentation of the subject, wherein the ceramide alleviates skin irritation caused by the retinol, and wherein the ceramide is represented by Chemical Formula 2: wherein n is 1 or 2; and each of R and R′ represents a C 9 -C 21 saturated or unsaturated aliphatic chain. 2. The method according to claim 1 , wherein the improving skin condition of the subject comprises improving or treating acne of the subject. 3. The method according to claim 1 , wherein the improving skin condition of the subject comprises controlling sebum of the subject. 4. The method according to claim 1 , wherein the improving skin condition of the subject comprises controlling pores of the subject. 5. The method according to claim 1 , wherein the improving skin condition of the subject comprises improving or treating skin pigmentation of the subject.
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Anti-acne agents · CPC title
Amidines ([IMAGE cpc-sch-A61K-1029.gif]), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2) · CPC title
Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal · CPC title
Retinol compounds, e.g. vitamin A (retinoic acids A61K31/203) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.